Dexrazoxane for Preventing Anthracycline Cardiotoxicity in Children with Solid Tumors

This study attempted to assess the incidence and outcome of anthracycline cardiotoxicity and the role of dexrazoxane as a cardioprotectant in childhood solid tumors. The dexrazoxane group included 47 patients and the control group of historical cohort included 42. Dexrazoxane was given in the 10:1 r...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hyoung Soo, Park, Eun Sil, Kang, Hyoung Jin, Shin, Hee Young, Noh, Chung Il, Yun, Yong Soo, Ahn, Hyo Seop, Choi, Jung Yun
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923785/
https://www.ncbi.nlm.nih.gov/pubmed/20808678
http://dx.doi.org/10.3346/jkms.2010.25.9.1336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923785/
https://www.ncbi.nlm.nih.gov/pubmed/20808678
http://dx.doi.org/10.3346/jkms.2010.25.9.1336

Ejemplares similares